TXT2STAYQUIT: Pilot Randomized Trial of Brief Automated Smoking Cessation Texting Intervention for Inpatient Smokers Discharged from the Hospital
© 2018 Society of Hospital Medicine
Acknowledgments
The authors gratefully acknowledge those in the respiratory care department at Penn State Health Milton S. Hershey Medical Center for their assistance in the recruitment for this study and providing inpatient smoking cessation counseling.
Disclosure
Dr. Foulds has done paid consulting for pharmaceutical companies that are involved in producing smoking cessation medications, including GlaxoSmithKline, Pfizer, Novartis, Johnson and Johnson, and Cypress Bioscience Inc. All other authors declare that they have no potential conflicts of interest to disclose.
Funding
The project described was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through an internal pilot grant (PI: JF) as part of parent grant to Penn State CTSI: Grant UL1 TR000127 and TR002014. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
